| Ireland | 001-37757 | 98-1328821 | ||||||
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification Number) | ||||||
25 North Wall Quay Dublin 1, Ireland D01 H104 | ||
| (Address of principal executive offices) | ||
| Not applicable | ||
| Title of class | Trading symbol(s) | Name of exchange on which registered | ||||||||||||
| Ordinary Shares, par value $0.001 | ADNT | New York Stock Exchange | ||||||||||||
| EXHIBIT INDEX | ||||||||
| Exhibit No. | Exhibit Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (the Cover Page Interactive Data File is embedded within the Inline XBRL document). | |||||||
| ADIENT PLC | ||||||||
| Date: February 4, 2026 | By: | /s/ Heather M. Tiltmann | ||||||
| Name: | Heather M. Tiltmann | |||||||
| Title: | Executive Vice President, Chief Legal and Human Resources Officer, and Corporate Secretary | |||||||




| Three Months Ended December 31, | ||||||||||||||
| (in millions, except per share data) | 2025 | 2024 | ||||||||||||
| Net sales | $ | 3,644 | $ | 3,495 | ||||||||||
| Cost of sales | 3,427 | 3,279 | ||||||||||||
| Gross profit | 217 | 216 | ||||||||||||
| Selling, general and administrative expenses | 130 | 125 | ||||||||||||
| Restructuring and impairment costs | 24 | 23 | ||||||||||||
| Equity income | 27 | 25 | ||||||||||||
| Earnings before interest and income taxes | 90 | 93 | ||||||||||||
| Net financing charges | 48 | 45 | ||||||||||||
| Other pension expense | 1 | 1 | ||||||||||||
| Income before income taxes | 41 | 47 | ||||||||||||
| Income tax provision | 42 | 22 | ||||||||||||
| Net income (loss) | (1) | 25 | ||||||||||||
| Income attributable to noncontrolling interests | 21 | 25 | ||||||||||||
| Net income (loss) attributable to Adient | $ | (22) | $ | — | ||||||||||
| Diluted earnings (loss) per share | $ | (0.28) | $ | — | ||||||||||
| Shares outstanding at period end | 78.3 | 83.9 | ||||||||||||
| Diluted weighted average shares | 78.7 | 84.7 | ||||||||||||
| December 31 | September 30, | |||||||||||||
| (in millions) | 2025 | 2025 | ||||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 855 | $ | 958 | ||||||||||
Accounts receivable - net | 1,638 | 1,873 | ||||||||||||
| Inventories | 760 | 695 | ||||||||||||
| Other current assets | 663 | 607 | ||||||||||||
| Current assets | 3,916 | 4,133 | ||||||||||||
| Property, plant and equipment - net | 1,401 | 1,409 | ||||||||||||
| Goodwill | 1,812 | 1,807 | ||||||||||||
| Other intangible assets - net | 313 | 319 | ||||||||||||
| Investments in partially-owned affiliates | 312 | 276 | ||||||||||||
| Assets held for sale | 12 | 9 | ||||||||||||
| Other noncurrent assets | 1,008 | 1,001 | ||||||||||||
| Total assets | $ | 8,774 | $ | 8,954 | ||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||
| Short-term debt | $ | 11 | $ | 11 | ||||||||||
| Accounts payable and accrued expenses | 2,850 | 2,942 | ||||||||||||
| Other current liabilities | 731 | 734 | ||||||||||||
| Current liabilities | 3,592 | 3,687 | ||||||||||||
| Long-term debt | 2,380 | 2,386 | ||||||||||||
| Other noncurrent liabilities | 705 | 723 | ||||||||||||
| Redeemable noncontrolling interests | 68 | 95 | ||||||||||||
| Shareholders' equity attributable to Adient | 1,735 | 1,766 | ||||||||||||
| Noncontrolling interests | 294 | 297 | ||||||||||||
| Total liabilities and shareholders' equity | $ | 8,774 | $ | 8,954 | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2025 | 2024 | ||||||||||||
| Operating Activities | ||||||||||||||
| Net income (loss) attributable to Adient | $ | (22) | $ | — | ||||||||||
| Income attributable to noncontrolling interests | 21 | 25 | ||||||||||||
| Net income (loss) | (1) | 25 | ||||||||||||
| Adjustments to reconcile net income to cash provided (used) by operating activities: | ||||||||||||||
| Depreciation | 69 | 69 | ||||||||||||
| Amortization of intangibles | 11 | 11 | ||||||||||||
| Pension and postretirement benefit expense | 3 | 2 | ||||||||||||
| Pension and postretirement contributions, net | — | (8) | ||||||||||||
| Equity in earnings of partially-owned affiliates, net of dividends received | (27) | (15) | ||||||||||||
| Gain on sale of interests in nonconsolidated partially-owned affiliates | — | (4) | ||||||||||||
| Deferred income taxes | (2) | 7 | ||||||||||||
| Non-cash impairment charges | — | 10 | ||||||||||||
| Equity-based compensation | 8 | 5 | ||||||||||||
| Other | 2 | (3) | ||||||||||||
| Changes in assets and liabilities: | ||||||||||||||
| Receivables | 243 | 402 | ||||||||||||
| Inventories | (65) | 6 | ||||||||||||
| Other assets | (42) | (70) | ||||||||||||
| Accounts payable and accrued liabilities | (143) | (329) | ||||||||||||
| Accrued income taxes | 24 | 1 | ||||||||||||
| Cash provided by operating activities | 80 | 109 | ||||||||||||
| Investing Activities | ||||||||||||||
| Capital expenditures | (65) | (64) | ||||||||||||
| Sale of property, plant and equipment | 2 | 6 | ||||||||||||
| Business divestitures | — | 27 | ||||||||||||
| Investments in partially-owned affiliates | (4) | (3) | ||||||||||||
| Other | (1) | — | ||||||||||||
| Cash used by investing activities | (68) | (34) | ||||||||||||
| Financing Activities | ||||||||||||||
| Increase (decrease) in short-term debt | — | (1) | ||||||||||||
| Repayment of long-term debt | (2) | (2) | ||||||||||||
| Debt financing costs | (6) | (1) | ||||||||||||
| Share repurchases | (25) | (25) | ||||||||||||
| Acquisition of a noncontrolling interest | — | (28) | ||||||||||||
| Dividends paid to noncontrolling interests | (76) | (42) | ||||||||||||
| Share based compensation and other | (5) | (3) | ||||||||||||
| Cash used by financing activities | (114) | (102) | ||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | (1) | (58) | ||||||||||||
| Decrease in cash and cash equivalents | $ | (103) | $ | (85) | ||||||||||
| (in millions) | Three months ended December 31, 2025 | |||||||||||||||||||||||||||||||
| Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
| Net sales | $ | 1,642 | $ | 1,205 | $ | 819 | $ | (22) | $ | 3,644 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 80 | $ | 34 | $ | 115 | $ | (22) | $ | 207 | ||||||||||||||||||||||
| Adjusted EBITDA margin | 4.9 | % | 2.8 | % | 14.0 | % | N/A | 5.7 | % | |||||||||||||||||||||||
| Three months ended December 31, 2024 | ||||||||||||||||||||||||||||||||
| Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
| Net sales | $ | 1,611 | $ | 1,129 | $ | 772 | $ | (17) | $ | 3,495 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 85 | $ | 22 | $ | 111 | $ | (22) | $ | 196 | ||||||||||||||||||||||
| Adjusted EBITDA margin | 5.3 | % | 1.9 | % | 14.4 | % | N/A | 5.6 | % | |||||||||||||||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2025 | 2024 | ||||||||||||
| Adjusted EBITDA | ||||||||||||||
| Americas | $ | 80 | $ | 85 | ||||||||||
| EMEA | 34 | 22 | ||||||||||||
| Asia | 115 | 111 | ||||||||||||
| Subtotal | 229 | 218 | ||||||||||||
Corporate-related costs (1) | (22) | (22) | ||||||||||||
Restructuring and impairment costs (2) | (24) | (23) | ||||||||||||
Purchase accounting amortization (3) | (11) | (11) | ||||||||||||
Restructuring related activities (4) | (7) | (1) | ||||||||||||
Gain (loss) on disposal transactions (5) | — | 4 | ||||||||||||
| Equity based compensation | (8) | (5) | ||||||||||||
| Depreciation | (69) | (69) | ||||||||||||
Other items (6) | 2 | 2 | ||||||||||||
| Earnings before interest and income taxes | $ | 90 | $ | 93 | ||||||||||
| Net financing charges | (48) | (45) | ||||||||||||
| Other pension expense | (1) | (1) | ||||||||||||
| Income before income taxes | $ | 41 | $ | 47 | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions, except per share data) | 2025 | 2024 | ||||||||||||
| Income available to shareholders | ||||||||||||||
| Net income (loss) attributable to Adient | $ | (22) | $ | — | ||||||||||
| Weighted average shares outstanding | ||||||||||||||
| Basic weighted average shares outstanding | 78.7 | 84.4 | ||||||||||||
| Effect of dilutive securities: | ||||||||||||||
| Unvested restricted stock and unvested performance share awards | — | 0.3 | ||||||||||||
| Diluted weighted average shares outstanding | 78.7 | 84.7 | ||||||||||||
| Earnings (loss) per share: | ||||||||||||||
| Basic | $ | (0.28) | $ | — | ||||||||||
| Diluted | $ | (0.28) | $ | — | ||||||||||
| (a) | Adjusted EBIT is defined as earnings before income taxes and noncontrolling interests excluding net financing charges, restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, and net mark-to-market adjustments on pension and postretirement plans. Adjusted EBIT margin is adjusted EBIT as a percentage of net sales. | ||||
| (b) | Adjusted EBITDA is defined as adjusted EBIT excluding depreciation and equity based compensation. Certain corporate-related costs are not allocated to the business segments in determining adjusted EBITDA. Adjusted EBITDA margin is adjusted EBITDA as a percentage of net sales. | ||||
| (c) | Adjusted net income attributable to Adient is defined as net income (loss) attributable to Adient excluding restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, net mark-to-market adjustments on pension and postretirement plans, the tax impact of these items and other discrete tax charges/benefits. | ||||
| (d) | Adjusted income tax expense is defined as income tax expense adjusted for the tax effect of the adjustments to income before income taxes and other discrete tax changes/benefits. Adjusted effective tax rate is defined as adjusted income tax provision as a percentage of adjusted income before income taxes. | ||||
| (e) | Adjusted diluted earnings per share is defined as adjusted net income attributable to Adient divided by diluted weighted average shares. | ||||
| (f) | Adjusted equity income is defined as equity income excluding amortization of Adient's intangible assets related to its non-consolidated joint ventures and other unusual or non-recurring items impacting equity income. | ||||
| (g) | Adjusted interest expense is defined as net financing charges excluding unusual or one-time items impacting interest expense. | ||||
| (h) | Free cash flow is defined as cash provided by operating activities less capital expenditures. | ||||
| (i) | Net debt is calculated as total debt (short-term and long-term) less cash and cash equivalents. | ||||
| (j) | Net leverage ratio is calculated as net debt divided by adjusted EBITDA for the last four quarters. | ||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2025 | 2024 | ||||||||||||
| Net income (loss) | $ | (1) | $ | 25 | ||||||||||
| Net financing charges | 48 | 45 | ||||||||||||
| Other pension expense | 1 | 1 | ||||||||||||
| Income tax expense | 42 | 22 | ||||||||||||
| Earnings before interest and income taxes (EBIT) | $ | 90 | $ | 93 | ||||||||||
| EBIT adjustments: | ||||||||||||||
Restructuring and impairment costs (2) | 24 | 23 | ||||||||||||
Purchase accounting amortization (3) | 11 | 11 | ||||||||||||
Restructuring related activities (4) | 7 | 1 | ||||||||||||
Gain on disposal transactions (5) | — | (4) | ||||||||||||
Other items (6) | (2) | (2) | ||||||||||||
| EBIT adjustments total | 40 | 29 | ||||||||||||
| Adjusted EBIT | $ | 130 | $ | 122 | ||||||||||
| EBITDA adjustments: | ||||||||||||||
| Depreciation | 69 | 69 | ||||||||||||
| Equity based compensation | 8 | 5 | ||||||||||||
| Adjusted EBITDA | $ | 207 | $ | 196 | ||||||||||
| Net sales | $ | 3,644 | $ | 3,495 | ||||||||||
| Net income as % of net sales | — | % | 0.7 | % | ||||||||||
| EBIT as % of net sales | 2.5 | % | 2.7 | % | ||||||||||
| Adjusted EBIT as % of net sales | 3.6 | % | 3.5 | % | ||||||||||
| Adjusted EBITDA as % of net sales | 5.7 | % | 5.6 | % | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2025 | 2024 | ||||||||||||
| Net income (loss) attributable to Adient | $ | (22) | $ | — | ||||||||||
| Net income adjustments: | ||||||||||||||
| EBIT adjustments total - see table (a) & (b) | 40 | 29 | ||||||||||||
| Tax impact of EBIT adjustments and other tax items - see table (d) | 12 | (4) | ||||||||||||
Impact of adjustments on noncontrolling interests (7) | (2) | (2) | ||||||||||||
| Net income adjustments total | 50 | 23 | ||||||||||||
| Adjusted net income attributable to Adient | $ | 28 | $ | 23 | ||||||||||
| Three months ended December 31, | ||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||||||||||||||
| (in millions, except effective tax rate) | Income before income taxes | Income tax expense (benefit) | Effective tax rate | Income before income taxes | Income tax expense (benefit) | Effective tax rate | ||||||||||||||||||||||||||||||||
| As reported | $ | 41 | $ | 42 | nm | $ | 47 | $ | 22 | 46.8 | % | |||||||||||||||||||||||||||
| Adjustments | ||||||||||||||||||||||||||||||||||||||
| EBIT adjustments - see table (a) & (b) | 40 | 3 | 7.5 | % | 29 | 3 | 10.3 | % | ||||||||||||||||||||||||||||||
| Tax audit closures and statute expirations | — | 10 | nm | — | 7 | nm | ||||||||||||||||||||||||||||||||
| UTP establishments and interest | — | (24) | nm | — | (1) | nm | ||||||||||||||||||||||||||||||||
| FX remeasurements of tax balances | — | 1 | nm | — | (6) | nm | ||||||||||||||||||||||||||||||||
| Other | — | (2) | nm | — | 1 | nm | ||||||||||||||||||||||||||||||||
| Subtotal of adjustments | 40 | (12) | (30.0) | % | 29 | 4 | 13.8 | % | ||||||||||||||||||||||||||||||
| As adjusted | $ | 81 | $ | 30 | 37.0 | % | $ | 76 | $ | 26 | 34.2 | % | ||||||||||||||||||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions, except per share data) | 2025 | 2024 | ||||||||||||
| Numerator: | ||||||||||||||
| Adjusted net income attributable to Adient - see table (c) | $ | 28 | $ | 23 | ||||||||||
| Denominator: | ||||||||||||||
| Basic weighted average shares outstanding | 78.7 | 84.4 | ||||||||||||
| Effect of dilutive securities: | ||||||||||||||
| Unvested restricted stock and unvested performance share awards | 0.7 | 0.3 | ||||||||||||
| Diluted weighted average shares outstanding | 79.4 | 84.7 | ||||||||||||
| Adjusted diluted earnings per share | $ | 0.35 | $ | 0.27 | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| 2025 | 2024 | |||||||||||||
| Diluted earnings (loss) per share as reported | $ | (0.28) | $ | — | ||||||||||
| EBIT adjustments total | 0.51 | 0.34 | ||||||||||||
| Tax impact of EBIT adjustments and other tax items | 0.15 | (0.05) | ||||||||||||
| Impact of adjustments on noncontrolling interests | (0.03) | (0.02) | ||||||||||||
| Adjusted diluted earnings per share | $ | 0.35 | $ | 0.27 | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2025 | 2024 | ||||||||||||
| Equity income | $ | 27 | $ | 25 | ||||||||||
| Equity income adjustments: | ||||||||||||||
| Gain on sale of Setex | — | (4) | ||||||||||||
| Restructuring charges at affiliates | 2 | — | ||||||||||||
| Equity income adjustments total | 2 | (4) | ||||||||||||
| Adjusted equity income | $ | 29 | $ | 21 | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2025 | 2024 | ||||||||||||
| Net financing charges | $ | 48 | $ | 45 | ||||||||||
| Interest expense adjustments: | ||||||||||||||
| None | — | — | ||||||||||||
| Interest expense adjustments total | — | — | ||||||||||||
| Adjusted net financing charges | $ | 48 | $ | 45 | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2025 | 2024 | ||||||||||||
| Operating cash flow | $ | 80 | $ | 109 | ||||||||||
| Capital expenditures | (65) | (64) | ||||||||||||
| Free cash flow | $ | 15 | $ | 45 | ||||||||||
| Three Months Ended December 31, | ||||||||||||||
| (in millions) | 2025 | 2024 | ||||||||||||
| Adjusted EBITDA | $ | 207 | $ | 196 | ||||||||||
| Adjusted equity income | (29) | (21) | ||||||||||||
| Dividends from partially owned affiliates | — | 6 | ||||||||||||
| Restructuring (cash) | (19) | (34) | ||||||||||||
| Net customer tooling | 10 | (16) | ||||||||||||
| Trade working capital (Net AR/AP + Inventory) | 187 | 234 | ||||||||||||
| Accrued compensation | (76) | (78) | ||||||||||||
| Interest paid | (54) | (54) | ||||||||||||
| Tax refund/taxes paid | (20) | (15) | ||||||||||||
| Non-income related taxes (VAT) | (44) | (22) | ||||||||||||
| Commercial settlements | (37) | (9) | ||||||||||||
| Net capitalized engineering | 6 | 5 | ||||||||||||
| Other | (51) | (83) | ||||||||||||
| Operating cash flow | 80 | 109 | ||||||||||||
| Capital expenditures | (65) | (64) | ||||||||||||
| Free cash flow | $ | 15 | $ | 45 | ||||||||||
| December 31 | September 30, | |||||||||||||
| (in millions) | 2025 | 2025 | ||||||||||||
| Numerator: | ||||||||||||||
| Short-term debt | $ | 2 | $ | 2 | ||||||||||
| Current portion of long-term debt | 9 | 9 | ||||||||||||
| Long-term debt | 2,380 | 2,386 | ||||||||||||
| Total debt | 2,391 | 2,397 | ||||||||||||
| Less: cash and cash equivalents | 855 | 958 | ||||||||||||
| Net debt | $ | 1,536 | $ | 1,439 | ||||||||||
| Denominator: | ||||||||||||||
| Adjusted EBITDA - last four quarters | ||||||||||||||
| Q1 2025 | na | $ | 196 | |||||||||||
| Q2 2025 | $ | 233 | 233 | |||||||||||
| Q3 2025 | 226 | 226 | ||||||||||||
| Q4 2025 | 226 | 226 | ||||||||||||
| Q1 2026 - see table (a) & (b) | 207 | na | ||||||||||||
| Last four quarters | $ | 892 | $ | 881 | ||||||||||
| Net leverage ratio | 1.72 | 1.63 | ||||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2025 | 2024 | ||||||||||||
| Restructuring related charges | $ | (5) | $ | (6) | ||||||||||
| Restructuring charges at affiliates | (2) | — | ||||||||||||
| Gain of sale of a restructured facility | — | 5 | ||||||||||||
| $ | (7) | $ | (1) | |||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2025 | 2024 | ||||||||||||
| Gain on sale of Setex | $ | — | $ | 4 | ||||||||||
| $ | — | $ | 4 | |||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2025 | 2024 | ||||||||||||
| Non-recurring contract related settlement | $ | 2 | $ | 2 | ||||||||||
| $ | 2 | $ | 2 | |||||||||||